Metabolic and cardiovascular effects of early insulin glargin prescription: based on data from ORIGIN study

Metabolic and cardiovascular effects of early insulin glargin prescription: based on data from ORIGIN study

We discuss results of ORIGIN, a multicenter parallel groups study for efficiency assessment of insulin glargin against polyunsaturatedomega-3 fatty acids or placebo regarding cardiovascular and/or mortality risk reduction in patients with impaired fasting glycemia,impaired glucose tolerance or type...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Elena Valer'evna Biryukova, Alexander Sergeevich Ametov, Mikhail Borisovich Antsiferov, Alsu Gafurovna Zalevskaya, Galina Afanas'evna Mel'nichenko, Ashot Musaelovich Mkrtumyan, Marina Vladimirovna Shestakova
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2012
Materias:
prediabetes
diabetes mellitus
hypoglycemia
oncology
onsulin glargin
origin study
Nutritional diseases. Deficiency diseases
RC620-627
Acceso en línea:https://doaj.org/article/b7e6d26cdbee4110988b38b6e29a334f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/b7e6d26cdbee4110988b38b6e29a334f

Ejemplares similares